- Home
- UCAR vs CLRB Comparison
UCAR vs CLRB Comparison
Compare UCAR & CLRB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UCAR
- CLRB
- Stock Information
- Founded
- UCAR 2013
- CLRB 2002
- Country
- UCAR China
- CLRB United States
- Employees
- UCAR N/A
- CLRB N/A
- Industry
- UCAR Retail-Auto Dealers and Gas Stations
- CLRB Biotechnology: Pharmaceutical Preparations
- Sector
- UCAR Consumer Discretionary
- CLRB Health Care
- Exchange
- UCAR Nasdaq
- CLRB Nasdaq
- Market Cap
- UCAR 13.3M
- CLRB 12.5M
- IPO Year
- UCAR 2023
- CLRB N/A
- Fundamental
- Price
- UCAR $3.86
- CLRB $7.90
- Analyst Decision
- UCAR
- CLRB Hold
- Analyst Count
- UCAR 0
- CLRB 2
- Target Price
- UCAR N/A
- CLRB N/A
- AVG Volume (30 Days)
- UCAR 52.7K
- CLRB 1.3M
- Earning Date
- UCAR 07-07-2025
- CLRB 08-12-2025
- Dividend Yield
- UCAR N/A
- CLRB N/A
- EPS Growth
- UCAR N/A
- CLRB N/A
- EPS
- UCAR N/A
- CLRB N/A
- Revenue
- UCAR $6,067,871.00
- CLRB N/A
- Revenue This Year
- UCAR N/A
- CLRB N/A
- Revenue Next Year
- UCAR N/A
- CLRB N/A
- P/E Ratio
- UCAR N/A
- CLRB N/A
- Revenue Growth
- UCAR 124.09
- CLRB N/A
- 52 Week Low
- UCAR $2.30
- CLRB $6.50
- 52 Week High
- UCAR $9.43
- CLRB $94.50
- Technical
- Relative Strength Index (RSI)
- UCAR 58.97
- CLRB 40.04
- Support Level
- UCAR $3.53
- CLRB $9.60
- Resistance Level
- UCAR $4.32
- CLRB $10.19
- Average True Range (ATR)
- UCAR 0.39
- CLRB 1.57
- MACD
- UCAR 0.04
- CLRB -0.50
- Stochastic Oscillator
- UCAR 58.17
- CLRB 11.58
About UCAR U Power Limited
U Power Ltd is involved in the provision of vehicle sourcing services. It is principally engaged in the provision of new energy vehicles development and sales; battery swapping stations manufacturing and sales; battery swapping services, and sourcing services. The company, as a broker, engaged in sales of vehicles between automobile wholesalers and buyers, including small and medium-sized vehicle dealers and individual customers located in lower-tier cities in China.
About CLRB Cellectar Biosciences Inc.
Cellectar Biosciences Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of drugs for the treatment of cancer. The company's core objective is to leverage a proprietary phospholipid drug conjugate (PDC) delivery platform to develop PDCs that are designed to specifically target cancer cells and deliver improved efficacy and safety as a result of fewer off-target effects. It has one operating and reportable segment focused on utilizing its PDC platform to develop drugs for the treatment of cancer.